DocDollars

Teva Pharmaceuticals USA, Inc.

NJ · United States · Reporting entity ID 100000000141

Total reported 2019–2025
$357.5M
#44 of 2,960 reporting companies — 0.4% of all reported industry payments
$81.0M in general payments across 806,538 records, plus $276.5M in research funding across 42,986 records.

How it breaks down

General payments $80,954,205
Research funding $276,495,895

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Teva Pharmaceuticals USA, Inc. reported $357.5M to US doctors and teaching hospitals from 2019 to 2025, ranking #44 of 2,960 reporting companies. 77% of that was research funding and 23% general payments such as consulting, speaking, food and travel. 806,538 general payment records and 42,986 research records were filed.

Common questions about Teva Pharmaceuticals USA, Inc.

How much has Teva Pharmaceuticals USA, Inc. paid US doctors?

Teva Pharmaceuticals USA, Inc. reported $357,450,100 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $80,954,205 in general payments, $276,495,895 in research funding.

How does Teva Pharmaceuticals USA, Inc. rank among drug and device companies?

It ranks #44 of 2,960 reporting entities by total reported value, about 0.4% of all industry payments in the dataset.

Does a payment from Teva Pharmaceuticals USA, Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.